8.—(1) In regulation 8(1) (general interpretation) of the Human Medicines Regulations 2012(1), after the definition “electronic communication”, insert—
““electronic signature” has the meaning given within Article 3(10) of Regulation (EU) 910/2014 of the European Parliament and of the Council on electronic identification and trust services for electronic transactions in the internal market;”.
(2) In regulation 219(5) (electronic prescriptions) of the Human Medicines Regulations 2012, for the definition of “advanced electronic signature”, substitute—
““advanced electronic signature” has the meaning given within Article 3(11) of Regulation (EU) No 910/2014 of the European Parliament and of the Council on electronic identification and trust services for electronic transactions in the internal market;”.
S.I. 2012/1916; amended by S.I. 2015/903; there are other amending instruments but none is relevant.